BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 7026027)

  • 1. Immunobiological properties of 1-butanol-extracted cell surface antigens.
    LeGrue SJ; Allison JP; Macek CM; Pellis NR; Kahan BD
    Cancer Res; 1981 Oct; 41(10):3956-60. PubMed ID: 7026027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of 1-butanol-extracted murine tumor-specific transplantation antigens.
    LeGrue SJ; Pellis NR; Riley LB; Kahan BD
    Cancer Res; 1985 Jul; 45(7):3164-72. PubMed ID: 2408745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraction of a murine tumor-specific antigen from cells and plasma membranes using 1-butanol: augmentation of antigen yield by colchicine.
    LeGrue SJ; Kahan BD
    Cancer Res; 1985 May; 45(5):1926-9. PubMed ID: 4039219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed hypersensitivity to crude and partially purified murine tumor-specific transplantation antigens and alloantigens utilizing the footpad swelling assay.
    Macek CM; Kahan BD; Pellis NR
    J Immunol; 1980 Oct; 125(4):1639-43. PubMed ID: 6157743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncytolytic extraction of murine tumor-specific transplantation antigens with the nonionic detergent octyl-beta-D-glucopyranoside.
    LeGrue SJ; Macek CM; Kahan BD
    J Natl Cancer Inst; 1982 Jul; 69(1):131-6. PubMed ID: 6954305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential extraction of tumor-specific antigens from two ultraviolet light-induced murine fibrosarcomas with the use of 1-butanol.
    Simcik WJ; Kripke ML; Sheu TL; LeGrue SJ
    Cancer Res; 1988 Dec; 48(24 Pt 1):7004-8. PubMed ID: 3142680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of tumor-specific cytolytic T lymphocytes using in vitro restimulation with tumor-specific transplantation antigen.
    Naito K; Pellis NR; Kahan BD
    Cell Immunol; 1987 Sep; 108(2):483-94. PubMed ID: 3113743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of radiolabeled alloantibodies in mice bearing 3-methylcholanthrene-induced sarcoma.
    Buchsbaum DJ; Walker PC; Johnson EA
    Cancer Res; 1979 Sep; 39(9):3363-8. PubMed ID: 476667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retardation of postsurgical metastases with the use of extracted tumor-specific transplantation antigens and cyclophosphamide.
    Nomi S; Pellis NR; Kahan BD
    J Natl Cancer Inst; 1984 Oct; 73(4):943-50. PubMed ID: 6237215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraction of a murine tumor-specific transplantation antigen with 1-butanol. I. Partial purification by isoelectric focusing.
    LeGrue SJ; Kahan BD; Pellis NR
    J Natl Cancer Inst; 1980 Jul; 65(1):191-6. PubMed ID: 6930513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
    Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
    Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapeutic effects of partially purified tumor-specific transplantation antigens on pulmonary metastases of a 3-methylcholanthrene-induced sarcoma in mice: a preliminary report.
    Tanaka T; Pellis NR; Kahan BD
    J Natl Cancer Inst; 1982 Nov; 69(5):1121-6. PubMed ID: 6957656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induction of immunogenic variant of a murine fibrosarcoma].
    Kobayashi M; Yamagishi H; Nomi S; Ueda Y; Hayashi T; Oka T
    Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1372-7. PubMed ID: 1448043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic variants of a murine fibrosarcoma induced by mutagenesis: requirement of viable cells for antigen-specific cross-protection.
    LeGrue SJ; Simcik WJ; Frost P
    Cancer Res; 1987 Aug; 47(16):4413-6. PubMed ID: 3607772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
    Vaage J
    Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential extraction of tumor-specific transplantation antigen and embryonic antigen from simian virus 40- and adenovirus 7-induced sarcoma cells of hamsters with 1-butanol and 3 M potassium chloride.
    Coggin JH; Gillis LD; Payne WJ
    J Natl Cancer Inst; 1984 Apr; 72(4):853-62. PubMed ID: 6323810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
    Kahan BD; Tanaka T; Pellis NR
    J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reacting antigens in chemically induced sarcomas are fetal determinants.
    Parker GA; Rosenberg SA
    J Immunol; 1977 May; 118(5):1590-4. PubMed ID: 67142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.
    Pellis NR; Tom BH; Kahan BD
    J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.